SCHEMBL26970922

SCHEMBL26970922

Cc1ccc(S(=O)(=O)OCc2cc(C)on2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
MAPT P10636 3/20 0.41
RECQL P46063 1/20 0.41
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
GBA1 P04062 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 2/20 0.39
MAPK1 P28482 2/20 0.38
BMP1 P13497 1/20 0.38
ADRA1A P35348 1/20 0.38
TSHR P16473 2/20 0.38
USP2 O75604 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GAPDH P04406 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27246864 0.85 EDNRB (0.39) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL3772018 0.84 SMN1; SMN2 (0.42) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL1087387 0.79 MAPT (0.40) MAPTRECQLALDH1A1KMT2ABMP1
SCHEMBL3760673 0.79 MEN1 (0.33) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL5788622 0.78 CA12 (0.36) MAPTMEN1KMT2ACA12CA1
SCHEMBL16388122 0.78 MEN1 (0.48) MAPTALDH1A1MEN1KMT2ACA12
SCHEMBL20570168 0.77 CA12 (0.33) MAPTMEN1KMT2ACA12CA1
SCHEMBL25318427 0.76 KEAP1 (0.44) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL18977857 0.76 KMT2A (0.40) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL34469410 0.75 SMN1; SMN2 (0.38) LMNAALDH1A1MEN1KMT2ABMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858918-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2024-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11858918-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 LMNA 3309/4885MAPT 3314/4885RECQL 3243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.